Home・Akcijų sąrašas・Zimmer Biomet Holdings Inc

Zimmer Biomet Holdings Inc

Atidarymo kaina

SektoriusSveikatos priežiūra

95.59 -0.94

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

94.16

Max

96.98

Pagrindiniai rodikliai
By Trading Economics
Pajamos	99M 239M
Pardavimai	-157M 2.1B
P/E Sektoriaus vid.	23.852 64.641
Pelnas, tenkantis vienai akcijai	2.09
Dividendų pajamingumas	1.05
Pelno marža	11.43
Darbuotojai	17,000
EBITDA	84M 538M

Rekomendacijos
By TipRanks
Rekomendacijos	Pirkti
12 mėnesių prognozė	+2.66% upside

Dividendai
By Acuity
Dividendų pajamingumas Sektoriaus vid.	1.05% 2.31%
Kitas uždarbis	2026-08-05
Kitas dividendų mokėjimo data	2026-10-30
Kita Ex Dividend data	2026-09-29

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	-110M 18B
Ankstesnė atidarymo kaina	96.53
Ankstesnė uždarymo kaina	95.59

Naujienos nuotaikos

By Acuity

31%

69%

97 / 340 reitingas Healthcare

Zimmer Biomet Holdings Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-08-03 23:11; UTC

Shares of Zimmer Biomet Holdings Inc. are lower in after-market hours, showing weakness despite earlier gains and remaining above their 20-day moving average.

2026-07-31 20:06; UTC

Correlated Moves

Zimmer Biomet Holdings Inc. shares are lower today, influenced by Stryker Corp's decline and broader market sentiment amid rising Treasury yields and inflation concerns.

2026-07-30 19:03; UTC

Zimmer Biomet Holdings Inc shares are lower today, breaking a trend of higher closes. Broader economic indicators may contribute to market uncertainty.

2026-07-29 17:46; UTC

Zimmer Biomet Holdings Inc shares are higher, continuing a positive trend since Tuesday's close. Broader market volatility is impacting sentiment amid rising oil prices.

2026-07-28 20:03; UTC

News

Social Media

UBS initiated coverage on Zimmer Biomet with a Buy rating and a $115 price target, supporting shares' advance during the current trading session.

2026-07-27 18:46; UTC

Correlated Moves

Zimmer Biomet Holdings Inc is advancing in Monday's session, supported by a broader rise in the medical devices sector amid declining crude oil prices.

2026-07-24 19:06; UTC

Correlated Moves

Zimmer Biomet Holdings is trading higher, benefiting from a pullback in crude oil prices and positive sentiment in the health care equipment sector.

2026-07-23 21:02; UTC

Zimmer Biomet Holdings Inc shares are lower in after-market hours. No specific news was identified to explain the price movement.

2026-07-22 18:36; UTC

Correlated Moves

Zimmer Biomet Holdings Inc reported first-quarter adjusted EPS of $1.08, below estimates. Shares are lower today amid broader sector declines and external market pressures.

2026-07-20 18:16; UTC

Zimmer Biomet Holdings Inc shares are lower amid unusual volatility and broader market concerns over rising yields and inflation fears linked to increasing oil prices.

Akcijų palyginimas

Kainos pokytis

Zimmer Biomet Holdings Inc Prognozė

Kainos tikslas

By TipRanks

2.66% į viršų

12 mėnesių prognozė

Vidutinis 99.56 USD 2.66%

Aukščiausias 115 USD

Žemiausias 83 USD

Remiantis 10 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Zimmer Biomet Holdings Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

10 ratings

Pirkti

Laikyti

Parduoti

Remiantis 10 analitikų, pateikusių Zimmer Biomet Holdings Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Rinkos nuotaikos

By Acuity

97 / 340 reitingas Sveikatos priežiūra

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Zimmer Biomet Holdings Inc

Zimmer Biomet Holdings, Inc. is a global medical technology company. Its segments include Americas, EMEA, and Asia Pacific. The Company designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; craniomaxillofacial and thoracic (CMFT) products; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its other product category primarily includes its robotic, surgical and bone cement products. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee, and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System, and G7 Acetabular System. Its S.E.T. product category includes sports medicine, biologics, foot and others.